ArticleMolecules (Basel, Switzerland)2022

Design of SARS-CoV-2 Main Protease Inhibitors Using Artificial Intelligence and Molecular Dynamic Simulations.

Lars Elend et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.